INSULET CORPORATION Revenue
INSULET CORPORATION (PODD) reported Revenue of $801.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-05
- INSULET CORPORATION revenues for the quarter ending 2026-06-30 was $801.70M, a 23.51% increase year-over-year.
- INSULET CORPORATION revenues for the quarter ending 2026-03-31 was $761.70M, a 33.87% increase year-over-year.
- INSULET CORPORATION revenues for the quarter ending 2025-12-31 was $783.80M, a 31.18% increase year-over-year.
- INSULET CORPORATION revenues for the quarter ending 2025-09-30 was $706.30M, a 29.86% increase year-over-year.
- INSULET CORPORATION revenues for fiscal 2025 was $2.71B, a 30.73% increase from fiscal 2024.
- INSULET CORPORATION revenues for fiscal 2024 was $2.07B, a 22.07% increase from fiscal 2023.
- INSULET CORPORATION revenues for fiscal 2023 was $1.70B, a 30.02% increase from fiscal 2022.
- INSULET CORPORATION revenues for fiscal 2022 was $1.31B, a 18.79% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-06-30 | $801.70M 10-Q · filed 2026-08-05 | $1.56B 10-Q · filed 2026-08-05 | $2.35B derived: sum of 3 quarters · filed 2026-08-05 | $3.05B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $761.70M 10-Q · filed 2026-05-06 | $1.55B derived: sum of 2 quarters · filed 2026-05-06 | $2.25B derived: sum of 3 quarters · filed 2026-05-06 | $2.90B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $783.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $1.49B derived: sum of 2 quarters · filed 2026-02-18 | $2.14B derived: sum of 3 quarters · filed 2026-08-05 | $2.71B 10-K · filed 2026-02-18 |
| 2025-09-30 | $706.30M 10-Q · filed 2025-11-06 | $1.36B derived: sum of 2 quarters · filed 2026-08-05 | $1.92B 10-Q · filed 2025-11-06 | $2.52B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $649.10M 10-Q · filed 2026-08-05 | $1.22B 10-Q · filed 2026-08-05 | $1.82B derived: sum of 3 quarters · filed 2026-08-05 | $2.36B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $569.00M 10-Q · filed 2026-05-06 | $1.17B derived: sum of 2 quarters · filed 2026-05-06 | $1.71B derived: sum of 3 quarters · filed 2026-05-06 | $2.20B derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $597.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $1.14B derived: sum of 2 quarters · filed 2026-02-18 | $1.63B derived: sum of 3 quarters · filed 2026-02-18 | $2.07B 10-K · filed 2026-02-18 |
| 2024-09-30 | $543.90M 10-Q · filed 2025-11-06 | $1.03B derived: sum of 2 quarters · filed 2025-11-06 | $1.47B 10-Q · filed 2025-11-06 | $1.98B derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-06-30 | $488.50M 10-Q · filed 2025-08-07 | $930.20M 10-Q · filed 2025-08-07 | $1.44B derived: sum of 3 quarters · filed 2026-02-18 | $1.87B derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-03-31 | $441.70M 10-Q · filed 2025-05-09 | $951.50M derived: sum of 2 quarters · filed 2026-02-18 | $1.38B derived: sum of 3 quarters · filed 2026-02-18 | $1.78B derived: sum of 4 quarters · filed 2026-02-18 |
| 2023-12-31 | $509.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $942.50M derived: sum of 2 quarters · filed 2026-02-18 | $1.34B derived: sum of 3 quarters · filed 2026-02-18 | $1.70B 10-K · filed 2026-02-18 |
| 2023-09-30 | $432.70M 10-Q · filed 2024-11-08 | $829.20M derived: sum of 2 quarters · filed 2024-11-08 | $1.19B 10-Q · filed 2024-11-08 | $1.56B derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $396.50M 10-Q · filed 2024-08-09 | $754.60M 10-Q · filed 2024-08-09 | $1.12B derived: sum of 3 quarters · filed 2025-02-21 | $1.47B derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $358.10M 10-Q · filed 2024-05-10 | $727.80M derived: sum of 2 quarters · filed 2025-02-21 | $1.07B derived: sum of 3 quarters · filed 2025-02-21 | $1.37B derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-31 | $369.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $710.50M derived: sum of 2 quarters · filed 2025-02-21 | $1.01B derived: sum of 3 quarters · filed 2025-02-21 | $1.31B 10-K · filed 2025-02-21 |
| 2022-09-30 | $340.80M 10-Q · filed 2023-11-03 | $640.20M derived: sum of 2 quarters · filed 2023-11-03 | $935.60M 10-Q · filed 2023-11-03 | $1.24B derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $299.40M 10-Q · filed 2023-08-09 | $594.80M 10-Q · filed 2023-08-09 | $902.50M derived: sum of 3 quarters · filed 2024-02-23 | $1.18B derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $295.40M 10-Q · filed 2023-05-05 | $603.10M derived: sum of 2 quarters · filed 2024-02-23 | $878.70M derived: sum of 3 quarters · filed 2024-02-23 | $1.14B derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $307.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $583.30M derived: sum of 2 quarters · filed 2024-02-23 | $846.50M derived: sum of 3 quarters · filed 2024-02-23 | $1.10B 10-K · filed 2024-02-23 |
| 2021-09-30 | $275.60M 10-Q · filed 2022-11-04 | $538.80M derived: sum of 2 quarters · filed 2022-11-04 | $791.10M 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $263.20M 10-Q · filed 2022-08-05 | $515.50M 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | $252.30M 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | $904.40M 10-K · filed 2023-02-24 | |||
| 2017-12-31 | $130.52M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $252.30M derived: sum of 2 quarters · filed 2018-02-22 | $362.06M derived: sum of 3 quarters · filed 2018-02-22 | $463.77M 10-K · filed 2018-02-22 |
| 2017-09-30 | $121.78M 10-Q · filed 2017-11-03 | $231.53M derived: sum of 2 quarters · filed 2017-11-03 | $333.24M 10-Q · filed 2017-11-03 | $436.82M derived: sum of 4 quarters · filed 2018-02-22 |
| 2017-06-30 | $109.76M 10-Q · filed 2017-08-04 | $211.47M 10-Q · filed 2017-08-04 | $315.04M derived: sum of 3 quarters · filed 2018-02-22 | $409.92M derived: sum of 4 quarters · filed 2018-02-22 |
| 2017-03-31 | $101.71M 10-Q · filed 2017-05-09 | $205.29M derived: sum of 2 quarters · filed 2018-02-22 | $300.16M derived: sum of 3 quarters · filed 2018-02-22 | $387.49M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-12-31 | $103.58M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $198.45M derived: sum of 2 quarters · filed 2018-02-22 | $285.78M derived: sum of 3 quarters · filed 2018-02-22 | $366.99M 10-K · filed 2018-02-22 |
| 2016-09-30 | $94.87M 10-Q · filed 2017-11-03 | $182.20M derived: sum of 2 quarters · filed 2017-11-03 | $263.41M 10-Q · filed 2017-11-03 | $347.21M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-06-30 | $87.33M 10-Q · filed 2017-08-04 | $168.54M 10-Q · filed 2017-08-04 | $252.34M derived: sum of 3 quarters · filed 2018-02-22 | $323.74M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-03-31 | $81.21M 10-Q · filed 2017-05-09 | $165.01M derived: sum of 2 quarters · filed 2018-02-22 | $236.41M derived: sum of 3 quarters · filed 2018-02-22 | $296.96M derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | $83.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $155.19M derived: sum of 2 quarters · filed 2018-02-22 | $215.75M derived: sum of 3 quarters · filed 2018-02-22 | $263.89M 10-K · filed 2018-02-22 |
| 2015-09-30 | $71.39M 10-Q · filed 2016-11-04 | $131.94M derived: sum of 2 quarters · filed 2016-11-04 | $180.09M 10-Q · filed 2016-11-04 | |
| 2015-06-30 | $60.55M 10-Q · filed 2016-08-04 | $108.70M 10-Q · filed 2016-08-04 | ||
| 2014-12-31 | $231.32M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |